Plain-English translation of NCT03334292 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term study that follows patients with Wilson disease — a rare genetic condition affecting how your body handles copper — to understand how the disease naturally progresses. Researchers at top Wilson disease treatment centers in the United States and United Kingdom will collect information about your health, test results, and treatment responses over time. The goal is to develop better ways to diagnose the disease and monitor whether treatments like chelation therapy and zinc supplements are working.
Wilson disease is rare, and doctors still need better tools to track how well patients are responding to treatment. By following many patients over time and gathering detailed health information, researchers hope to find reliable ways to measure treatment success and improve care for future patients.
You likely qualify if…
You likely don't qualify if…
You will be followed at one of the specialized Wilson disease treatment centers, where your doctors will collect information about your health, symptoms, and test results at regular visits. This is not a treatment study — you will continue your current care — but rather researchers will track how you are doing over time. The study aims to enroll 300 patients and will gather data to help improve how doctors monitor and treat Wilson disease in the future.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
United States
Germany
Sponsor
Yale University
Collaborators
Wilson Disease Association
Enrollment target
~300 participants
Started
December 2017
Primary completion
November 2029
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ricarda Tomlin
Yale University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.